Top

Published in:

Open Access 01-12-2014 | ORIGINAL PAPER

Circulating Tumor Cells: Who is the Killer?

Author: Patrizia Paterlini-Bréchot

Published in: Cancer Microenvironment | Issue 3/2014

Abstract

This article is a critical note on the subject of Circulating Tumor Cells (CTC). It takes into account the tumor identity of Circulating Tumor Cells as cancer seeds in transit from primary to secondary soils, rather than as a “biomarker”, and considers the help this field could bring to cancer patients. It is not meant to duplicate information already available in a large number of reviews, but to stimulate considerations, further studies and development helping the clinical use of tumor cells isolated from blood as a modern personalized, non-invasive, predictive test to improve cancer patients’ life. The analysis of CTC challenges, methodological bias and critical issues points out to the need of referring to tumor cells extracted from blood without any bias and identified by cytopathological diagnosis as Circulating Cancer Cells (CCC). Finally, this article highlights recent developments and identifies burning questions which should be addressed to improve our understanding of the domain of CCC and their potential to change the clinical practice.

Yap TA, Lorente D, Omlin A, Olmos D, de Bono JS (2014) Circulating tumor cells: a multifunctional biomarker. Clin Cancer Res: Off J Am Assoc Cancer Res 20(10):2553–2568. doi:10.1158/1078-0432.CCR-13-2664

Tinhofer I, Saki M, Niehr F, Keilholz U, Budach V (2014) Cancer stem cell characteristics of circulating tumor cells. Int J Radiat Biol 90(8):622–627. doi:10.3109/09553002.2014.886798 PubMed

Rodic S, Mihalcioiu C, Saleh RR (2014) Detection methods of circulating tumor cells in cutaneous melanoma: a systematic review. Crit Rev Oncol Hematol 91(1):74–92. doi:10.1016/j.critrevonc.2014.01.007 PubMed

Mateo J, Gerlinger M, Rodrigues D, de Bono JS (2014) The promise of circulating tumor cell analysis in cancer management. Genome Biol 15(8):448. doi:10.1186/s13059-014-0448-5 PubMed

Lowes LE, Allan AL (2014) Recent advances in the molecular characterization of circulating tumor cells. Cancer 6(1):595–624. doi:10.3390/cancers6010595

Lorente D, Mateo J, de Bono JS (2014) Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancer. Am Soc Clin Oncol Ed Book / ASCO Am Soc Clin Oncol Meet:e197–203. doi 10.14694/EdBook_AM.2014.34.e197

Liu H, Zhang X, Li J, Sun B, Qian H, Yin Z (2014) The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells. J Cancer Res Clin Oncol. doi:10.1007/s00432-014-1752-x

Krebs MG, Metcalf RL, Carter L, Brady G, Blackhall FH, Dive C (2014) Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol 11(3):129–144. doi:10.1038/nrclinonc.2013.253 PubMed

Castle J, Shaker H, Morris K, Tugwood JD, Kirwan CC (2014) The significance of circulating tumour cells in breast cancer: a review. Breast 23(5):552–560. doi:10.1016/j.breast.2014.07.002 PubMed

10.

Becker TM, Caixeiro NJ, Lim SH, Tognela A, Kienzle N, Scott KF, Spring KJ, de Souza P (2014) New frontiers in circulating tumor cell analysis: a reference guide for biomolecular profiling toward translational clinical use. Int J Cancer J Int Cancer 134(11):2523–2533. doi:10.1002/ijc.28516

11.

Raimondi C, Gradilone A, Naso G, Cortesi E, Gazzaniga P (2014) Clinical utility of circulating tumor cell counting through cell search ((R)): the dilemma of a concept suspended in Limbo. Oncol Targets Ther 7:619–625. doi:10.2147/OTT.S46200

12.

Lugassy C (2014) Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination. Cancer Microenviron

13.

Paterlini-Brechot P, Benali NL (2007) Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253(2):180–204. doi:10.1016/j.canlet.2006.12.014 PubMed

14.

Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38(9):2651–2660PubMed

15.

Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153(3):865–873. doi:10.1016/S0002-9440(10)65628-3 PubMedCentralPubMed

16.

Alix-Panabieres C, Pantel K (2014) Challenges in circulating tumour cell research. Nat Rev Cancer 14(9):623–631. doi:10.1038/nrc3820 PubMed

17.

Glaves D (1983) Correlation between circulating cancer cells and incidence of metastases. Br J Cancer 48(5):665–673PubMedCentralPubMed

18.

Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172(7):973–981. doi:10.1083/jcb.200601018 PubMedCentralPubMed

19.

Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, Toner M, Haber DA, Maheswaran S (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584. doi:10.1126/science.1228522 PubMedCentralPubMed

20.

Tam WL, Weinberg RA (2013) The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 19(11):1438–1449. doi:10.1038/nm.3336 PubMedCentralPubMed

21.

Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bauerle T, Wallwiener M, Holland-Letz T, Hofner T, Sprick M, Scharpff M, Marme F, Sinn HP, Pantel K, Weichert W, Trumpp A (2013) Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31(6):539–544. doi:10.1038/nbt.2576 PubMed

22.

Easwaran H, Tsai HC, Baylin SB (2014) Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 54(5):716–727. doi:10.1016/j.molcel.2014.05.015 PubMed

23.

Giordano A, Gao H, Anfossi S, Cohen E, Mego M, Lee BN, Tin S, De Laurentiis M, Parker CA, Alvarez RH, Valero V, Ueno NT, De Placido S, Mani SA, Esteva FJ, Cristofanilli M, Reuben JM (2012) Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer. Mol Cancer Ther 11(11):2526–2534. doi:10.1158/1535-7163.MCT-12-0460 PubMedCentralPubMed

24.

Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, Desai R, Zhu H, Comaills V, Zheng Z, Wittner BS, Stojanov P, Brachtel E, Sgroi D, Kapur R, Shioda T, Ting DT, Ramaswamy S, Getz G, Iafrate AJ, Benes C, Toner M, Maheswaran S, Haber DA (2014) Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345(6193):216–220. doi:10.1126/science.1253533 PubMed

25.

Zhang L, Ridgway LD, Wetzel MD, Ngo J, Yin W, Kumar D, Goodman JC, Groves MD, Marchetti D (2013) The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med 5(180):180ra148. doi:10.1126/scitranslmed.3005109

26.

Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD, Stanger BZ (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148(1–2):349–361. doi:10.1016/j.cell.2011.11.025 PubMedCentralPubMed

27.

Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883–892. doi:10.1056/NEJMoa1113205 PubMed

28.

Yap TA, Gerlinger M, Futreal PA, Pusztai L, Swanton C (2012) Intratumor heterogeneity: seeing the wood for the trees. Sci Transl Med 4(127):127ps110. doi:10.1126/scitranslmed.3003854

29.

Vlashi E, Pajonk F (2014) Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol. doi:10.1016/j.semcancer.2014.07.001 PubMed

30.

Fidler IJ (1970) Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2’-deoxyuridine. J Natl Cancer Inst 45(4):773–782PubMed

31.

Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, Assmann G, Zanker KS (1996) Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res 56(20):4556–4561PubMed

32.

Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Brechot C, Paterlini-Brechot P (2000) Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156(1):57–63. doi:10.1016/S0002-9440(10)64706-2 PubMedCentralPubMed

33.

Hou JM, Krebs M, Ward T, Sloane R, Priest L, Hughes A, Clack G, Ranson M, Blackhall F, Dive C (2011) Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 178(3):989–996. doi:10.1016/j.ajpath.2010.12.003 PubMedCentralPubMed

34.

Duda DG, Duyverman AM, Kohno M, Snuderl M, Steller EJ, Fukumura D, Jain RK (2010) Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci U S A 107(50):21677–21682. doi:10.1073/pnas.1016234107 PubMedCentralPubMed

35.

Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M, Haber DA, Maheswaran S (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5):1110–1122. doi:10.1016/j.cell.2014.07.013 PubMed

36.

Ting DT, Wittner BS, Ligorio M, Vincent Jordan N, Shah AM, Miyamoto DT, Aceto N, Bersani F, Brannigan BW, Xega K, Ciciliano JC, Zhu H, MacKenzie OC, Trautwein J, Arora KS, Shahid M, Ellis HL, Qu N, Bardeesy N, Rivera MN, Deshpande V, Ferrone CR, Kapur R, Ramaswamy S, Shioda T, Toner M, Maheswaran S, Haber DA (2014) Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell Rep 8(6):1905–1918. doi:10.1016/j.celrep.2014.08.029 PubMed

37.

Hoshimoto S, Shingai T, Morton DL, Kuo C, Faries MB, Chong K, Elashoff D, Wang HJ, Elashoff RM, Hoon DS (2012) Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. J Clin Oncol: Off J Am Soc Clin Oncol 30(31):3819–3826. doi:10.1200/JCO.2011.40.0887

38.

Kiyohara E, Hata K, Lam S, Hoon DS (2014) Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients. Methods Mol Biol 1102:513–522. doi:10.1007/978-1-62703-727-3_27 PubMed

39.

Mejean A, Vona G, Nalpas B, Damotte D, Brousse N, Chretien Y, Dufour B, Lacour B, Brechot C, Paterlini-Brechot P (2000) Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence. J Urol 163(6):2022–2029PubMed

40.

Sharma D, Brummel-Ziedins KE, Bouchard BA, Holmes CE (2014) Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol 229(8):1005–1015. doi:10.1002/jcp.24539 PubMed

41.

Erpenbeck L, Schon MP (2010) Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 115(17):3427–3436. doi:10.1182/blood-2009-10-247296 PubMedCentralPubMed

42.

Amo L, Tamayo-Orbegozo E, Maruri N, Eguizabal C, Zenarruzabeitia O, Rinon M, Arrieta A, Santos S, Monge J, Vesga MA, Borrego F, Larrucea S (2014) Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Front Oncol 4:245. doi:10.3389/fonc.2014.00245 PubMedCentralPubMed

43.

Lou XL, Deng J, Deng H, Ting Y, Zhou L, Liu YH, Hu JP, Huang XF, Qi XQ (2014) Aspirin inhibit platelet-induced epithelial-to-mesenchymal transition of circulating tumor cells (Review). Biomed Rep 2(3):331–334. doi:10.3892/br.2014.242 PubMedCentralPubMed

44.

Louha M, Nicolet J, Zylberberg H, Sabile A, Vons C, Vona G, Poussin K, Tournebize M, Capron F, Pol S, Franco D, Lacour B, Brechot C, Paterlini-Brechot P (1999) Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology 29(3):879–882. doi:10.1002/hep.510290348 PubMed

45.

Pantel K, Deneve E, Nocca D, Coffy A, Vendrell JP, Maudelonde T, Riethdorf S, Alix-Panabieres C (2012) Circulating epithelial cells in patients with benign colon diseases. Clin Chem 58(5):936–940. doi:10.1373/clinchem.2011.175570 PubMed

46.

Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Flejou JF, Lantuejoul S, Piaton E, Mourad N, Butori C, Selva E, Poudenx M, Sibon S, Kelhef S, Venissac N, Jais JP, Mouroux J, Molina TJ, Hofman P (2011) Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res: Off J Am Assoc Cancer Res 17(4):827–835. doi:10.1158/1078-0432.CCR-10-0445

47.

Bertolini F, Mancuso P, Benayoun L, Gingis-Velitski S, Shaked Y (2012) Evaluation of circulating endothelial precursor cells in cancer patients. Methods Mol Biol 904:165–172. doi:10.1007/978-1-61779-943-3_14 PubMed

48.

Mancuso P, Calleri A, Bertolini F (2012) Circulating endothelial cells and circulating endothelial progenitors. Recent Res Cancer Res Fortschr Krebsforschung Prog Rech Cancer 195:163–170. doi:10.1007/978-3-642-28160-0_14

49.

Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, Schrier SL, Weissman IL (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A 108(50):20012–20017. doi:10.1073/pnas.1116110108 PubMedCentralPubMed

50.

Wu WC, Sun HW, Chen HT, Liang J, Yu XJ, Wu C, Wang Z, Zheng L (2014) Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proc Natl Acad Sci U S A 111(11):4221–4226. doi:10.1073/pnas.1320753111 PubMedCentralPubMed

51.

Teo GS, Yang Z, Carman CV, Karp JM, Lin CP (2014) Intravital imaging of mesenchymal stem cell trafficking and association with platelets and neutrophils. Stem Cells. doi:10.1002/stem.1848

52.

Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res: Off J Am Assoc Cancer Res 10(20):6897–6904. doi:10.1158/1078-0432.CCR-04-0378

53.

Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Janicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K (2007) Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell Search system. Clin Cancer Res: Off J Am Assoc Cancer Res 13(3):920–928. doi:10.1158/1078-0432.CCR-06-1695

54.

Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781–791. doi:10.1056/NEJMoa040766 PubMed

55.

de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res: Off J Am Assoc Cancer Res 14(19):6302–6309. doi:10.1158/1078-0432.CCR-08-0872

56.

Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, Meropol NJ (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol: Off J Am Soc Clin Oncol 26(19):3213–3221. doi:10.1200/JCO.2007.15.8923

57.

Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, Board R, Clack G, Hughes A, Blackhall F, Valle JW, Dive C (2012) A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer 106(3):508–516. doi:10.1038/bjc.2011.545 PubMedCentralPubMed

58.

Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, Dive C (2012) Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol: Off J Am Soc Clin Oncol 30(5):525–532. doi:10.1200/JCO.2010.33.3716

59.

Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F, Laplanche A, Chauchereau A, Lacroix L, Planchard D, Le Moulec S, Andre F, Fizazi K, Soria JC, Vielh P (2011) A direct comparison of cell search and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer 105(6):847–853. doi:10.1038/bjc.2011.294 PubMedCentralPubMed

60.

Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC Jr, American Society of Clinical O (2007) American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol 25(33):5287–5312. doi:10.1200/JCO.2007.14.2364

61.

Zhang L, Riethdorf S, Wu G, Wang T, Yang K, Peng G, Liu J, Pantel K (2012) Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res: Off J Am Assoc Cancer Res 18(20):5701–5710. doi:10.1158/1078-0432.CCR-12-1587

62.

Chinen LT, de Carvalho FM, Rocha BM, Aguiar CM, Abdallah EA, Campanha D, Mingues NB, de Oliveira TB, Maciel MS, Cervantes GM, Dettino AL, Soares FA, Paterlini-Brechot P, Fanelli MF (2013) Cytokeratin-based CTC counting unrelated to clinical follow up. J Thorac Dis 5(5):593–599. doi:10.3978/j.issn. 2072-1439.2013.09.18 PubMedCentralPubMed

63.

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173):1235–1239. doi:10.1038/nature06385 PubMedCentralPubMed

64.

Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP Jr, Gilman AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV, Lee RJ, Isselbacher KJ, Maheswaran S, Haber DA, Toner M (2010) Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 107(43):18392–18397. doi:10.1073/pnas.1012539107 PubMedCentralPubMed

65.

Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E, Yu M, Chen PI, Morgan B, Trautwein J, Kimura A, Sengupta S, Stott SL, Karabacak NM, Barber TA, Walsh JR, Smith K, Spuhler PS, Sullivan JP, Lee RJ, Ting DT, Luo X, Shaw AT, Bardia A, Sequist LV, Louis DN, Maheswaran S, Kapur R, Haber DA, Toner M (2013) Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med 5(179):179ra147. doi:10.1126/scitranslmed.3005616

66.

Harb W, Fan A, Tran T, Danila DC, Keys D, Schwartz M, Ionescu-Zanetti C (2013) Mutational analysis of circulating tumor cells using a novel microfluidic collection device and qPCR assay. Transl Oncol 6(5):528–538PubMedCentralPubMed

67.

Talasaz AH, Powell AA, Huber DE, Berbee JG, Roh KH, Yu W, Xiao W, Davis MM, Pease RF, Mindrinos MN, Jeffrey SS, Davis RW (2009) Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A 106(10):3970–3975. doi:10.1073/pnas.0813188106 PubMedCentralPubMed

68.

Saucedo-Zeni N, Mewes S, Niestroj R, Gasiorowski L, Murawa D, Nowaczyk P, Tomasi T, Weber E, Dworacki G, Morgenthaler NG, Jansen H, Propping C, Sterzynska K, Dyszkiewicz W, Zabel M, Kiechle M, Reuning U, Schmitt M, Lucke K (2012) A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int J Oncol 41(4):1241–1250. doi:10.3892/ijo.2012.1557 PubMedCentralPubMed

69.

Zippelius A, Kufer P, Honold G, Kollermann MW, Oberneder R, Schlimok G, Riethmuller G, Pantel K (1997) Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol: Off J Am Soc Clin Oncol 15(7):2701–2708

70.

Demel U, Tilz GP, Foeldes-Papp Z, Gutierrez B, Albert WH, Bocher O (2004) Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay. J Exp Clin Cancer Res: CR 23(3):465–468PubMed

71.

Ramirez JM, Fehm T, Orsini M, Cayrefourcq L, Maudelonde T, Pantel K, Alix-Panabieres C (2014) Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients. Clin Chem 60(1):214–221. doi:10.1373/clinchem.2013.215079 PubMed

72.

Friedlander TW, Ngo VT, Dong H, Premasekharan G, Weinberg V, Doty S, Zhao Q, Gilbert EG, Ryan CJ, Chen WT, Paris PL (2014) Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer. Int J Cancer J Int Cancer 134(10):2284–2293. doi:10.1002/ijc.28561

73.

Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani F, Polanski R, Burt DJ, Simpson KL, Morris K, Pepper SD, Nonaka D, Greystoke A, Kelly P, Bola B, Krebs MG, Antonello J, Ayub M, Faulkner S, Priest L, Carter L, Tate C, Miller CJ, Blackhall F, Brady G, Dive C (2014) Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 20(8):897–903. doi:10.1038/nm.3600 PubMed

74.

Yang L, Lang JC, Balasubramanian P, Jatana KR, Schuller D, Agrawal A, Zborowski M, Chalmers JJ (2009) Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng 102(2):521–534. doi:10.1002/bit.22066 PubMedCentralPubMed

75.

Shibata K, Mori M, Kitano S, Akiyoshi T (1998) Detection of ras gene mutations in peripheral blood of carcinoma patients using CD45 immunomagnetic separation and nested mutant allele specific amplification. Int J Oncol 12(6):1333–1338PubMed

76.

Coumans FA, van Dalum G, Beck M, Terstappen LW (2013) Filter characteristics influencing circulating tumor cell enrichment from whole blood. PLoS ONE 8(4):e61770. doi:10.1371/journal.pone.0061770 PubMedCentralPubMed

77.

Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, Wu Y, Carothers S, Berger M, Ramaswamy B, Macrae ER, Wesolowski R, Layman RM, Mrozek E, Pan X, Summers TA, Shapiro CL, Chalmers JJ (2014) Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients. Breast Cancer Res: BCR 16(2):R23. doi:10.1186/bcr3622 PubMedCentralPubMed

78.

Ilie M, Long E, Hofman V, Selva E, Bonnetaud C, Boyer J, Venissac N, Sanfiorenzo C, Ferrua B, Marquette CH, Mouroux J, Hofman P (2014) Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer. Br J Cancer 110(5):1236–1243. doi:10.1038/bjc.2014.11 PubMed

79.

Sabile A, Louha M, Bonte E, Poussin K, Vona G, Mejean A, Chretien Y, Bougas L, Lacour B, Capron F, Roseto A, Brechot C, Paterlini-Brechot P (1999) Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol 112(2):171–178PubMed

80.

Hofman VJ, Ilie MI, Bonnetaud C, Selva E, Long E, Molina T, Vignaud JM, Flejou JF, Lantuejoul S, Piaton E, Butori C, Mourad N, Poudenx M, Bahadoran P, Sibon S, Guevara N, Santini J, Venissac N, Mouroux J, Vielh P, Hofman PM (2011) Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol 135(1):146–156. doi:10.1309/AJCP9X8OZBEIQVVI PubMed

81.

Hofman V, Long E, Ilie M, Bonnetaud C, Vignaud JM, Flejou JF, Lantuejoul S, Piaton E, Mourad N, Butori C, Selva E, Marquette CH, Poudenx M, Sibon S, Kelhef S, Venissac N, Jais JP, Mouroux J, Molina TJ, Vielh P, Hofman P (2011) Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method. Cytopathology. doi:10.1111/j.1365-2303.2010.00835.x

82.

Vona G, Beroud C, Benachi A, Quenette A, Bonnefont JP, Romana S, Dumez Y, Lacour B, Paterlini-Brechot P (2002) Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood. Am J Pathol 160(1):51–58. doi:10.1016/S0002-9440(10)64348-9 PubMedCentralPubMed

83.

Beroud C, Karliova M, Bonnefont JP, Benachi A, Munnich A, Dumez Y, Lacour B, Paterlini-Brechot P (2003) Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells. Lancet 361(9362):1013–1014PubMed

84.

Saker A, Benachi A, Bonnefont JP, Munnich A, Dumez Y, Lacour B, Paterlini-Brechot P (2006) Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis. Prenat Diagn 26(10):906–916. doi:10.1002/pd.1524 PubMed

85.

Mouawia H, Saker A, Jais JP, Benachi A, Bussieres L, Lacour B, Bonnefont JP, Frydman R, Simpson JL, Paterlini-Brechot P (2012) Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy. Reprod Biomed Online 25(5):508–520. doi:10.1016/j.rbmo.2012.08.002 PubMed

86.

Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, Ranson M, Blackhall FH, Dive C (2012) Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol: Off Publ Int Assoc Stud Lung Cancer 7(2):306–315. doi:10.1097/JTO.0b013e31823c5c16

87.

Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F (2011) Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer 105(9):1338–1341. doi:10.1038/bjc.2011.405 PubMedCentralPubMed

88.

Pailler E, Adam J, Barthelemy A, Oulhen M, Auger N, Valent A, Borget I, Planchard D, Taylor M, Andre F, Soria JC, Vielh P, Besse B, Farace F (2013) Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer. J Clin Oncol: Off J Am Soc Clin Oncol 31(18):2273–2281. doi:10.1200/JCO.2012.44.5932

89.

Hofman V, Ilie MI, Long E, Selva E, Bonnetaud C, Molina T, Venissac N, Mouroux J, Vielh P, Hofman P (2011) Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small cell lung carcinoma: comparison of the efficacy of the cell search assay and the isolation by size of epithelial tumor cell method. Int J Cancer J Int Cancer. doi:10.1002/ijc.25819

90.

Pinzani P, Mazzini C, Salvianti F, Massi D, Grifoni R, Paoletti C, Ucci F, Molinara E, Orlando C, Pazzagli M, Neri B (2010) Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression. Melanoma Res 20(4):303–310. doi:10.1097/CMR.0b013e32833906e3 PubMed

91.

Mazzini C, Pinzani P, Salvianti F, Scatena C, Paglierani M, Ucci F, Pazzagli M, Massi D (2014) Circulating tumor cells detection and counting in uveal melanomas by a filtration-based method. Cancer 6(1):323–332. doi:10.3390/cancers6010323

92.

De Giorgi V, Pinzani P, Salvianti F, Panelos J, Paglierani M, Janowska A, Grazzini M, Wechsler J, Orlando C, Santucci M, Lotti T, Pazzagli M, Massi D (2010) Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. J Investig Dermatol 130(10):2440–2447. doi:10.1038/jid.2010.141 PubMed

93.

Hofman V, Ilie M, Long-Mira E, Giacchero D, Butori C, Dadone B, Selva E, Tanga V, Passeron T, Poissonnet G, Emile JF, Lacour JP, Bahadoran P, Hofman P (2013) Usefulness of immunocytochemistry for the detection of the BRAF (V600E) mutation in circulating tumor cells from metastatic melanoma patients. J Investig Dermatol 133(5):1378–1381. doi:10.1038/jid.2012.485 PubMed

94.

Khoja L, Shenjere P, Hodgson C, Hodgetts J, Clack G, Hughes A, Lorigan P, Dive C (2014) Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma. Melanoma Res 24(1):40–46. doi:10.1097/CMR.0000000000000025 PubMed

95.

Chinen LMC, Abdallah EA, Ocea LMM, Buim ME, Breve NM, Gasparini JL Jr, Fanelli MF, Paterlini-Bréchot P (2014) Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with diffrent types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion. Oncol Targets Ther 7:1609–1617

96.

Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res: Off J Am Assoc Cancer Res 10(24):8152–8162. doi:10.1158/1078-0432.CCR-04-1110

97.

Lee TK, Esinhart JD, Blackburn LD, Silverman JF (1992) The size of small cell lung carcinoma cells. Ratio to lymphocytes and correlation with specimen size and crush artifact. Anal Quant Cytol Histol Int Acad Cytol Am Soc Cytol 14(1):32–34

98.

Hou HW, Warkiani ME, Khoo BL, Li ZR, Soo RA, Tan DS, Lim WT, Han J, Bhagat AA, Lim CT (2013) Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci Rep 3:1259. doi:10.1038/srep01259 PubMedCentralPubMed

99.

Moon HS, Kwon K, Kim SI, Han H, Sohn J, Lee S, Jung HI (2011) Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). Lab Chip 11(6):1118–1125. doi:10.1039/c0lc00345j PubMed

100.

Gascoyne PR, Noshari J, Anderson TJ, Becker FF (2009) Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis 30(8):1388–1398. doi:10.1002/elps.200800373 PubMedCentralPubMed

101.

Fabbri F, Carloni S, Zoli W, Ulivi P, Gallerani G, Fici P, Chiadini E, Passardi A, Frassineti GL, Ragazzini A, Amadori D (2013) Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett 335(1):225–231. doi:10.1016/j.canlet.2013.02.015 PubMed

102.

Ilie M, Long E, Butori C, Hofman V, Coelle C, Mauro V, Zahaf K, Marquette CH, Mouroux J, Paterlini-Brechot P, Hofman P (2012) ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma. Ann Oncol: Off J Eur Soc Med Oncol ESMO 23(11):2907–2913. doi:10.1093/annonc/mds137

103.

Groesser L, Herschberger E, Landthaler M, Hafner C (2012) FGFR3, PIK3CA and RAS mutations in benign lichenoid keratosis. Br J dermatol 166(4):784–788. doi:10.1111/j.1365-2133.2011.10788.x PubMed

104.

Hafner C, Toll A, Fernandez-Casado A, Earl J, Marques M, Acquadro F, Mendez-Pertuz M, Urioste M, Malats N, Burns JE, Knowles MA, Cigudosa JC, Hartmann A, Vogt T, Landthaler M, Pujol RM, Real FX (2010) Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci U S A 107(48):20780–20785. doi:10.1073/pnas.1008365107 PubMedCentralPubMed

105.

Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW (2013) Cancer genome landscapes. Science 339(6127):1546–1558. doi:10.1126/science.1235122 PubMedCentralPubMed

106.

Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55(9):1856–1862PubMed

107.

Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud JM, Padovani B, Mouroux J, Marquette CH, Hofman P (2014) “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS ONE 9(10):e111597. doi:10.1371/journal.pone.0111597 PubMedCentralPubMed

108.

National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409. doi:10.1056/NEJMoa1102873 PubMed

109.

Strimbu K, Tavel JA (2010) What are biomarkers? Curr Opin HIV AIDS 5(6):463–466. doi:10.1097/COH.0b013e32833ed177 PubMedCentralPubMed

110.

Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland H, Lokeshwar V (2004) A side by side comparison of cytology and biomarkers for bladder cancer detection. J Urol 172(3):1123–1126. doi:10.1097/01.ju.0000134347.14643.ab PubMed

111.

Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus D, Meng S, Morrison L, Tucker T, Lane N, Ghadimi BM, Heselmeyer-Haddad K, Ried T, Rao C, Uhr J (2002) Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res: Off J Am Assoc Cancer Res 8(7):2073–2084

Title: Circulating Tumor Cells: Who is the Killer?
Author: Patrizia Paterlini-Bréchot
Publication date: 01-12-2014
Publisher: Springer Netherlands
Published in: Cancer Microenvironment / Issue 3/2014
Print ISSN: 1875-2292
Electronic ISSN: 1875-2284
DOI: https://doi.org/10.1007/s12307-014-0164-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Orthotopic Mouse Models of Tumor Metastasis Expressing Fluorescent Reporters Produce Imageable Circulating Tumor Cells

Pivotal Role of Pervasive Neoplastic and Stromal Cells Reprogramming in Circulating Tumor Cells Dissemination and Metastatic Colonization

Angiotropism, Pericytic Mimicry and Extravascular Migratory Metastasis in Melanoma: An Alternative to Intravascular Cancer Dissemination

Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment

About Seed and Soil

Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell’s Journey

Keynote webinar | Spotlight on antibody–drug conjugates in cancer